Ocular Health Articles & Analysis
4 news found
We are excited to leverage the deep expertise Ora has in bringing new ocular health therapies to market, to shape the upcoming Phase 3 trials for BRM421 and advance this novel DES therapy closer to ...
A summary of UBX1325 Phase 1 study was presented, and a symposium on the role of cellular senescence in ocular disease were both featured this week to more than 10,000 ophthalmologists and other experts in attendance. ...
LKC Technologies is pleased to announce that the Brazilian Health Regulatory Agency (Anvisa) has granted approval of the UTAS® device, making this a significant advancement in the preservation and enhancement of sight for patients in Brazil. ...
Details of the presentations are as follows: Title: Cellular senescence and immune response in ocular health and disease Session: Symposium Date & Time: Sunday, May 1 at 8:00-10:00 a.m. ...